keyword
https://read.qxmd.com/read/38635562/epidemiology-and-referral-patterns-of-patients-living-with-chronic-kidney-disease-in-johannesburg-south-africa-a-single-centre-experience
#1
JOURNAL ARTICLE
Yusuf Urade, Zaheera Cassimjee, Chandni Dayal, Sheetal Chiba, Adekunle Ajayi, Malcolm Davies
Chronic kidney disease (CKD) is a significant contributor to the global burden of non-communicable disease. Early intervention may facilitate slowing down of progression of CKD; recognition of at-risk patient groups may improve detection through screening. We retrospectively reviewed the clinical records of 960 patients attending a specialist nephrology outpatient clinic during the period 1 January 2011-31 December 2021. A significant proportion (47.8%) of patients were referred with established CKD stage G4 or G5...
2024: PLOS Glob Public Health
https://read.qxmd.com/read/38635476/tunable-q-factor-wavelet-transform-based-identification-of-diabetic-patients-using-ecg-signals
#2
JOURNAL ARTICLE
Anuja Jain, Anurag Verma, Amit Kumar Verma, Varun Bajaj
Diabetes is a chronic health condition that is characterized by increased levels of glucose (sugar) in the blood. It can have harmful effects on different parts of the body, such as the retina of the eyes, skin, nervous system, kidneys, and heart. Diabetes affects the structure of electrocardiogram (ECG) impulses by causing cardiovascular autonomic dysfunction. Multi-resolution analysis of the input ECG signal is utilized in this paper to develop a machine learning-based system for the automated detection of diabetic patients...
April 18, 2024: Computer Methods in Biomechanics and Biomedical Engineering
https://read.qxmd.com/read/38635113/dapagliflozin-and-empagliflozin-in-paediatric-indications-a-systematic-review
#3
Sebastiano A G Lava, Craig Laurence, Alessandro Di Deo, Nicole Sekarski, Michael Burch, Oscar Della Pasqua
INTRODUCTION: In adults, sodium-glucose cotransporter type 2 inhibitors have revolutionised the treatment of type 2 diabetes mellitus, heart failure, and chronic kidney disease. OBJECTIVE: We aimed to review information on compassionate use, clinical pharmacology, efficacy, and safety of dapagliflozin and empagliflozin in children. METHODS: We conducted a systematic review of published clinical trials, case reports, and observational studies in Medline, Excerpta Medica, and Web of Science databases from inception to September 2023...
April 18, 2024: Paediatric Drugs
https://read.qxmd.com/read/38634912/health-and-economic-impact-of-dapagliflozin-for-type-2-diabetes-patients-who-had-or-were-at-risk-for-atherosclerotic-cardiovascular-disease-in-the-italian-general-practitioners-setting-a-budget-impact-analysis
#4
JOURNAL ARTICLE
Paolo Angelo Cortesi, Ippazio Cosimo Antonazzo, Pasquale Palladino, Marco Gnesi, Silvia Mele, Marco D'Amelio, Elena Zanzottera Ferrari, Giampiero Mazzaglia, Lorenzo Giovanni Mantovani
AIM: In 2022, in Italy, general practitioners (GPs) have been allowed to prescribe SGLT2i in Type 2 Diabetes (T2D) under National Health Service (NHS) reimbursement. In the pivotal clinical trial named DECLARE-TIMI 58, dapagliflozin reduced the risk of hospitalization for heart failure, CV death and kidney disease progression compared to placebo in a population of T2D patients. This study evaluated the health and economic impact of dapagliflozin for T2D patients who had or were at risk for atherosclerotic cardiovascular disease in the Italian GPs setting...
April 18, 2024: Acta Diabetologica
https://read.qxmd.com/read/38634653/gliflozins-in-the-treatment-of-non-diabetic-experimental-cardiovascular-diseases
#5
JOURNAL ARTICLE
I Vaněčková, J Zicha
A new class of antidiabetic drugs - gliflozins (inhibitors of sodium glucose cotransporter-2; SGLT-2i) stimulate glucose and sodium excretion, thereby contributing to improved glycemic control, weight loss and blood pressure reduction in diabetic patients. Large clinical trials in patients with type 2 diabetes treated with empagliflozin, canagliflozin or dapagliflozin have demonstrated their excellent efficacy in improving many cardiovascular outcomes, including the reduction of death from cardiovascular diseases, non-fatal myocardial infarction or stroke, and hospitalization for heart failure...
April 18, 2024: Physiological Research
https://read.qxmd.com/read/38634619/theaflavin-3-3-digallate-protects-liver-and-kidney-functions-in-diabetic-rats-by-up-regulating-circ-itch-and-nrf2-signaling-pathway
#6
JOURNAL ARTICLE
Hongjuan Fu, Jianbo He, Cong Li, Chang Hui
Theaflavin-3,3'-digallate (TFDG) in black tea has a strong antioxidant capacity. However, its effect on diabetic liver and kidney injury and the underlying mechanisms remain unclear. In the present study, our findings indicated that TFDG administration effectively lowers the fasting blood glucose and serum lipid concentrations and enhances the functionality and cellular architecture of the liver and kidney in rats with diabetes. The data also showed that TFDG mitigates oxidative harm in the liver and kidney of rats afflicted with diabetes...
April 18, 2024: Journal of Agricultural and Food Chemistry
https://read.qxmd.com/read/38634412/medical-database-analysis-of-the-association-between-kidney-function-and-achievement-of-glycemic-control-in-older-japanese-adults-with-type%C3%A2-2-diabetes-who-started-with-oral-antidiabetic-drugs
#7
JOURNAL ARTICLE
Ryo Suzuki, Kiyoyasu Kazumori, Tatsuya Usui, Masahiko Shinohara
AIMS/INTRODUCTION: Despite the emergence of new drugs with novel mechanisms of action, treatment options for older people and those with chronic kidney disease are still limited. MATERIALS AND METHODS: Using a medical database compiled from Diagnostic Procedure Combination hospitals, we retrospectively analyzed treatment status, glycemic control and kidney function over 3 years after the first oral antidiabetic drugs in Japanese adults with type 2 diabetes who were aged ≥65 years...
April 18, 2024: Journal of Diabetes Investigation
https://read.qxmd.com/read/38634131/cannabinoid-receptor-type-1-activation-causes-a-water-diuresis-by-inducing-an-acute-central-diabetes-insipidus-in-mice
#8
JOURNAL ARTICLE
Joshua L Rein, Ken Mackie, Thomas R Kleyman, Lisa M Satlin
Cannabis and synthetic cannabinoid consumption is increasing worldwide. Cannabis contains numerous phytocannabinoids that act on the G-protein-coupled cannabinoid receptors type 1 (CB1R) and type 2 (CB2R) expressed throughout the body, including the kidney. Essentially every organ, including the kidney, produces endocannabinoids (ECs), endogenous ligands to these receptors. Cannabinoids acutely increase urine output in rodents and humans, thus potentially influencing total-body water and electrolyte homeostasis...
April 18, 2024: American Journal of Physiology. Renal Physiology
https://read.qxmd.com/read/38634072/the-impact-of-comorbidity-on-the-quality-of-life-of-people-who-recovered-from-covid-19-in-bangladesh
#9
JOURNAL ARTICLE
Md Abdullah Saeed Khan, Koustuv Dalal, Mehedi Hasan, Miah Md Akiful Haque, Nusrat-E-Mozid, Mosharop Hossian, Tajrin Rahman, Ramisha Maliha, Archi Mutsuddi, Md Utba Rashid, Mohammad Ali Hossain, Mohammad Hayatun Nabi, Mohammad Delwer Hossain Hawlader
OBJECTIVES: COVID-19 affects the quality of life (QoL) in a reverse way after recovery, which might be multiplied by the comorbid non-communicable diseases. This study explored the relationship between comorbidities and the QoL of people who recovered from COVID-19 in Bangladesh. METHODS: The cross-sectional study was conducted among 3244 participants between June 2020 and November 2020 using a pre-tested questionnaire through over-the-phone interviews. The WHOQOL-BREF was used to explore the QoL among the study participants...
June 2024: IJID Reg
https://read.qxmd.com/read/38633884/recurrent-gastric-antral-vascular-ectasia-a-single-center-experience
#10
JOURNAL ARTICLE
Andrea Cavallaro, Antonio Zanghì, Maria Di Vita, Vito Emanuele Catania, Giovanni Longo, Emanuele Lo Menzo, Roberta Granata, Maria Rosaria Valenti, Alessandro Cappellani, Simone Di Majo
INTRODUCTION: Gastric antral vascular ectasia (GAVE) is a rare cause of chronic or acute gastrointestinal bleeding. This condition accounts for ∼4% of upper gastrointestinal bleeding cases. This disease is often associated with systemic diseases, such as liver cirrhosis, chronic kidney failure, autoimmune conditions, diabetes mellitus, hypothyroidism, and cardiovascular diseases. However, its etiopathogenesis remains controversial. MATERIALS AND METHOD: We retrospectively reviewed the cases of GAVE treated at our digestive surgery unit...
2024: Frontiers in Surgery
https://read.qxmd.com/read/38633183/prevalence-and-antibiogram-of-shigatoxinproducing-e-coli-in-camel-meat-and-offal
#11
JOURNAL ARTICLE
Samah Ahmad Elkady, Wageh Sobhy Darwish, Ahmad E Tharwat, Mahmoud A Said, Dalia E ElAtriby, Marwa Magdy Seliem, Ahmed E Alfifi, Waleed R El-Ghareeb, Lamiaa M Reda, Tamer M Gad
BACKGROUND: Camels are important animals in Egypt and other Arab countries on the basis of their economic value and ethnic culture. Escherichia coli is implicated in several gastrointestinal infections and outbreaks worldwide, especially in developing countries. It causes infections that might lead to death. Numerous biological activities, such as antioxidative, antibacterial, anti-diabetic, anti-mutagenic, anti-inflammatory, neuroprotective, and diuretic, are associated with coriander and coriander essential oils...
January 2024: Open Veterinary Journal
https://read.qxmd.com/read/38633010/the-effect-of-vaccination-with-pfizer-biontech-or-coronavac-on-disease-prognosis-among-hospitalized-covid-19-patients
#12
JOURNAL ARTICLE
Mustafa Güldan, Sena Tuğana Ateş, Sebile Sarıoğlu, Sarp Suyabatmaz, Pelin İrkören, Süda Tekin, Mahir Kapmaz, Şiran Keske, Önder Ergönül
OBJECTIVE: The Turkish Ministry of Health offered two types of vaccines by January 13, 2021, which are CoronaVac (Sinovac Biotech, China) and Pfizer-BioNTech. We aimed to describe the impact of the CoronaVac and Pfizer-BioNTech vaccines on clinical outcomes among hospitalized patients during a six-month period. METHODS: We included patients older than 18 years old and hospitalized because of COVID-19 when the vaccines were available. We conducted the study at Koç University Hospital and American Hospital between June 2021, six months after the vaccination started, and December 2021...
June 2023: Infect Dis Clin Microbiol
https://read.qxmd.com/read/38631983/iridoids-modulate-inflammation-in-diabetic-kidney-disease-a-review
#13
REVIEW
Tong-Yi Zhou, Na Tian, Liu Li, Rong Yu
In recent years, preclinical research on diabetic kidney disease (DKD) has surged to the forefront of scientific and clinical attention. DKD has become a pervasive complication of type 2 diabetes. Given the complexity of its etiology and pathological mechanisms, current interventions, including drugs, dietary modifications, exercise, hypoglycemic treatments and lipid-lowering methods, often fall short in achieving desired therapeutic outcomes. Iridoids, primarily derived from the potent components of traditional herbs, have been the subject of long-standing research...
March 28, 2024: Journal of Integrative Medicine
https://read.qxmd.com/read/38630537/set7-methyltransferase-and-phenotypic-switch-in-diabetic-glomerular-endothelial-cells
#14
JOURNAL ARTICLE
Scott Maxwell, Jun Okabe, Harikrishnan Kaipananickal, Hanah Rodriguez, Ishant Khurana, Keith Al-Hasani, Bryna S M Chow, Eleni Pitsillou, Tom C Karagiannis, Karin Jandeleit-Dahm, Ronald C W Ma, Yu Huang, Juliana C N Chan, Mark E Cooper, Assam El-Osta
BACKGROUND: Hyperglycaemia influences the development of glomerular endothelial cell damage and nowhere is this more evident than in the progression of diabetic kidney disease (DKD). While the Set7 lysine methyltransferase is a known hyperglycaemic sensor, its role in endothelial cell function in the context of DKD remains poorly understood. METHODS: Single-cell transcriptomics was used to investigate Set7 regulation in a mouse model of DKD, followed by validation of findings using pharmacological and shRNA inhibition of Set7...
April 17, 2024: Journal of the American Society of Nephrology: JASN
https://read.qxmd.com/read/38630412/investigation-of-advanced-glycation-end-products-in-liver-adipose-and-renal-tissue-of-mice-on-a-high-fat-diet
#15
JOURNAL ARTICLE
Şermin Durak, Yasemin Yılmazer, Faruk Çelik, Ebrar Yeşiloğlu, Dilara Karaköse, Sena Dinçol, Sümeyye Uçak, Mustafa Yaman, Ümit Zeybek
Obesity is a complex condition associated with disruptions in carbohydrate, protein, and fat metabolism, linked to increased insulin resistance and glucose intolerance. High levels of Advanced Glycation End-products (AGEs) are associated with a range of chronic diseases, including kidney diseases, diabetic complications, cardiovascular diseases, and neurodegenerative diseases. Our study aims to investigate the accumulation of AGEs in the liver, renal and adipose tissues of mice fed a high-fat diet, contributing to a deeper understanding of obesity and its related metabolic disorders...
April 17, 2024: Cell Biochemistry and Biophysics
https://read.qxmd.com/read/38630340/alect2-amyloidosis-with-concurrent-igg4-related-interstitial-nephritis-membranous-nephropathy-and-diabetic-kidney-disease-a-case-report-and-literature-review
#16
JOURNAL ARTICLE
Muhammad Shaheen, Anchit Bharat, Allon N Friedman, Shunhua Guo
Leukocyte chemotactic factor-2 amyloidosis (ALECT2) is a recently described subtype of amyloidosis. IgG4-related disease is a rare fibroinflammatory condition characterized by dense interstitial lymphoplasmacytic infiltrates and fibrosis. Membranous nephropathy and diabetic nephropathy are common causes of nephrotic syndrome. Here we report a 49-year-old Hispanic male patient with diabetes mellitus who presented with jaundice and pruritus. IgG4-related autoimmune pancreatitis was diagnosed through laboratory workup and ampulla biopsy...
April 17, 2024: Journal of Nephrology
https://read.qxmd.com/read/38630049/advancements-in-diabetic-kidney-disease-management-integrating-innovative-therapies-and-targeted-drug-development
#17
REVIEW
Shaarav Ghose, Matthew Satariano, Saichidroopi Korada, Thomas Cahill, Raghav Shah, Rupesh Raina
Diabetic kidney disease (DKD) is a leading cause of chronic kidney disease and affects approximately 40% of diabetic individuals. Cases of DKD continue to rise globally as the prevalence of diabetes mellitus increases, with an estimated 415 million people living with diabetes in 2015 and a projected 642 million by 2040. DKD is associated with significant morbidity and mortality, representing 34% and 36% of all chronic kidney disease deaths in men and women, respectively. Common co-morbidities including hypertension and ageing-related nephron loss further complicate disease diagnosis and progression...
April 17, 2024: American Journal of Physiology. Endocrinology and Metabolism
https://read.qxmd.com/read/38629919/gestational-diabetes-mellitus-is-associated-with-greater-incidence-of-dementia-during-long-term-post-partum-follow-up
#18
JOURNAL ARTICLE
Yang Zhang, Darui Gao, Ying Gao, Jing Li, Chenglong Li, Yang Pan, Yongqian Wang, Junqing Zhang, Fanfan Zheng, Wuxiang Xie
BACKGROUND: The impact of gestational diabetes mellitus (GDM) on incident dementia is unknown. Our aim was to evaluate the relationship between GDM and all-cause dementia and the mediating effects of chronic diseases on this relationship. METHODS: This prospective cohort study included women from the UK Biobank who were grouped based on GDM history. Multivariate Cox proportional hazard models were used to explore the associations between GDM and dementia. We further analysed the mediating effects of chronic diseases on this relationship and the interactions of covariates...
April 17, 2024: Journal of Internal Medicine
https://read.qxmd.com/read/38629597/time-to-clinical-benefit-with-sotagliflozin-in-patients-with-type-2-diabetes-and-chronic-kidney-disease-insights-from-the-scored-randomized-trial
#19
JOURNAL ARTICLE
Rahul Aggarwal, Deepak L Bhatt, Michael Szarek, Lawrence A Leiter, Christopher P Cannon, Renato D Lopes, Michael J Davies, Phillip Banks, Bertram Pitt, Ph Gabriel Steg
No abstract text is available yet for this article.
April 17, 2024: European Journal of Heart Failure
https://read.qxmd.com/read/38629274/orphan-nuclear-receptor-nr4a3-promotes-vascular-calcification-via-histone-lactylation
#20
JOURNAL ARTICLE
Wenqi Ma, Kangni Jia, Haomai Cheng, Hong Xu, Zhigang Li, Hang Zhang, Hongyang Xie, Lingfang Zhuang, Ziyang Wang, Yuke Cui, Hang Sun, Lei Yi, Zhiyong Chen, Shengzhong Duan, Motoaki Sano, Keiichi Fukuda, Lin Lu, Fei Gao, Ruiyan Zhang, Xiaoxiang Yan
BACKGROUND: Medial arterial calcification is a chronic systemic vascular disorder distinct from atherosclerosis and is commonly observed in patients with chronic kidney disease, diabetes, and aging individuals. We previously showed that NR4A3 (nuclear receptor subfamily 4 group A member 3), an orphan nuclear receptor, is a key regulator in apo (apolipoprotein) A-IV-induced atherosclerosis progression; however, its role in vascular calcification is poorly understood. METHODS: We generated NR4A3-/- mice and 2 different types of medial arterial calcification models to investigate the biological roles of NR4A3 in vascular calcification...
April 17, 2024: Circulation Research
keyword
keyword
45649
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.